-
RNA Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Avidity Biosciences (RNA)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 222.66 mm | 222.66 mm | 222.66 mm | 222.66 mm | 222.66 mm | 222.66 mm |
Cash burn (monthly) | 50.11 mm | (no burn) | 40.33 mm | 31.58 mm | 33.29 mm | 25.07 mm |
Cash used (since last report) | 114.95 mm | n/a | 92.52 mm | 72.44 mm | 76.37 mm | 57.52 mm |
Cash remaining | 107.71 mm | n/a | 130.14 mm | 150.22 mm | 146.29 mm | 165.14 mm |
Runway (months of cash) | 2.1 | n/a | 3.2 | 4.8 | 4.4 | 6.6 |
13F holders | Current |
---|---|
Total holders | 237 |
Opened positions | 51 |
Closed positions | 59 |
Increased positions | 86 |
Reduced positions | 74 |
13F shares | Current |
---|---|
Total value | 3.36 tn |
Total shares | 134.90 mm |
Total puts | 717.10 k |
Total calls | 517.20 k |
Total put/call ratio | 1.4 |
Largest owners | Shares | Value |
---|---|---|
FMR | 16.51 mm | $480.10 bn |
T. Rowe Price | 11.04 mm | $321.13 mm |
BlackRock | 9.93 mm | $288.83 bn |
Vanguard | 9.43 mm | $274.28 bn |
Wellington Management | 8.11 mm | $235.73 bn |
RTW Investments | 7.93 mm | $230.69 bn |
Avoro Capital Advisors | 7.50 mm | $218.10 bn |
JHG Janus Henderson | 7.05 mm | $205.13 bn |
Ra Capital Management | 6.30 mm | $183.22 bn |
BMY Bristol-Myers Squibb | 5.08 mm | $219.36 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Mar 25 | Kathleen P. Gallagher | Common Stock | Sell | Dispose S | No | Yes | 29.414 | 5,875 | 172.81 k | 50,554 |
3 Mar 25 | Kathleen P. Gallagher | Common Stock | Option exercise | Acquire M | No | Yes | 14.7 | 5,875 | 86.36 k | 56,429 |
3 Mar 25 | Kathleen P. Gallagher | Stock Option Common Stock | Option exercise | Dispose M | No | No | 14.7 | 5,875 | 86.36 k | 19,375 |
3 Feb 25 | Kathleen P. Gallagher | Common Stock | Sell | Dispose S | No | Yes | 32.1563 | 5,875 | 188.92 k | 50,554 |
3 Feb 25 | Kathleen P. Gallagher | Common Stock | Option exercise | Acquire M | No | Yes | 16.65 | 5,875 | 97.82 k | 56,429 |
3 Feb 25 | Kathleen P. Gallagher | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 16.65 | 5,875 | 97.82 k | 34,675 |
22 Jan 25 | Kathleen P. Gallagher | Common Stock | Sell | Dispose S | No | Yes | 30.1609 | 5,629 | 169.78 k | 50,554 |
21 Jan 25 | Steven George Hughes | Common Stock | Sell | Dispose S | No | Yes | 28.5906 | 2,032 | 58.10 k | 82,428 |
21 Jan 25 | Steven George Hughes | Common Stock | Sell | Dispose S | No | Yes | 28.5955 | 1,915 | 54.76 k | 84,460 |
21 Jan 25 | Kathleen P. Gallagher | Common Stock | Sell | Dispose S | No | Yes | 28.593 | 1,817 | 51.95 k | 56,183 |